This is a discussion on FDA opens up access to experimental meds within the Biotechnology News forum, part of the Industry News and Updates category; Seriously ill patients with no remaining therapeutic options will be given access to experimental meds under new rules released by ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
|
|||
|
Seriously ill patients with no remaining therapeutic options will be given access to experimental meds under new rules released by the FDA. In the face of developers' worries that open access to experimental drugs could scuttle the clinical trial process, giving patients less reason to volunteer for a study, the agency has required that the developer and the FDA have to jointly agree on preclinical use of a drug. Patients can be charged for the cost of manufacturing and administering the drug. Report
More... |
![]() |
| Thread Tools | |
| Display Modes | |
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Access to Iplex for Patients with ALS | industry_news | FDA News | 0 | 07-27-2009 04:03 PM |
| Genzyme lines up $600M for personalized meds | industry_news | Biotechnology News | 0 | 02-25-2009 01:03 PM |
| Experimental Agent Significantly Improves Migraine Pain, Symptoms | industry_news | Other Clinical Pharmacy News | 0 | 06-30-2008 09:06 PM |